Myriad Genetics Inc.

PositionSalt Lake City - Investigational New Drug application - Alzheimer's treatment - Brief Article

MYRIAD GENETICS INC. has submitted an Investigational New Drug application for the evaluation of its drug R-flurbiprofen for the treatment and prevention of Alzheimer's disease. In the submitted Phase I trial, Myriad will establish the safety...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT